| Mona Akbari, | |
|
1085 Main St, South Weymouth, MA 02190-1547 | |
| (781) 331-2922 | |
| Not Available |
| Full Name | Mona Akbari |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1085 Main St, South Weymouth, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871720037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 252914 (Massachusetts) | Primary |
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194765438 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000918 |
News Archive
A new study from Indiana University provides evidence in mice that males may play a positive role in the development of offspring's brains starting before pregnancy.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
› Verified 2 days ago
| Entity Name | South Suburban Gastroenterology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114948478 PECOS PAC ID: 9931194412 Enrollment ID: O20040415000288 |
News Archive
A new study from Indiana University provides evidence in mice that males may play a positive role in the development of offspring's brains starting before pregnancy.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
› Verified 2 days ago
| Entity Name | Beth Israel Deaconess Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
A new study from Indiana University provides evidence in mice that males may play a positive role in the development of offspring's brains starting before pregnancy.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mona Akbari, 1085 Main St, South Weymouth, MA 02190-1547 Ph: (781) 331-2922 | Mona Akbari, 1085 Main St, South Weymouth, MA 02190-1547 Ph: (781) 331-2922 |
News Archive
A new study from Indiana University provides evidence in mice that males may play a positive role in the development of offspring's brains starting before pregnancy.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
› Verified 2 days ago
Ching Chan Reisig, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Rd # 73, South Weymouth, MA 02190 Phone: 781-624-8000 | |
Dr. Paul J. Schubert, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 541 Main St, Suite 400, South Weymouth, MA 02190 Phone: 781-952-1200 Fax: 781-340-1610 | |
Clayland F Cox, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1085 Main St, South Weymouth, MA 02190 Phone: 781-331-2922 | |
Aboualkheir Alzaim, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 540 Main St, South Weymouth, MA 02190 Phone: 781-340-6420 Fax: 781-340-6421 | |
Dr. Anahita Ghorbani, M.D., M.P.H Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 541 Main St Ste 400, South Weymouth, MA 02190 Phone: 781-952-1460 Fax: 781-340-1610 | |
Dr. Shail Maingi, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 101 Columbian St, South Weymouth, MA 02190 Phone: 518-525-5634 | |
Jessica E Viola, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Rd, South Shore Hospital, South Weymouth, MA 02190 Phone: 781-624-8000 |